STOCK TITAN

Crinetics Pharmaceuticals Inc - CRNX STOCK NEWS

Welcome to our dedicated news page for Crinetics Pharmaceuticals (Ticker: CRNX), a resource for investors and traders seeking the latest updates and insights on Crinetics Pharmaceuticals.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Crinetics Pharmaceuticals's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Crinetics Pharmaceuticals's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.56%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.86%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.63%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.22%
Tags
earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.08%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.69%
Tags
clinical trial
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.19%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.66%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.82%
Tags
management
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.65%
Tags
management
Crinetics Pharmaceuticals Inc

Nasdaq:CRNX

CRNX Rankings

CRNX Stock Data

3.65B
64.75M
1.92%
97.38%
6.43%
Research and Development in Biotechnology
Professional, Scientific, and Technical Services
Link
United States
San Diego

About CRNX

neuropeptide receptor targeted therapeutics for the treatment of endocrine diseases and cancers. we are driven by a passion for drug-hunting and tempered by a post-recession startup culture. our goal is to create new therapeutics that can make a meaningful difference in the lives of our patients.